REPCF:OTCMKTS
0913693 BC Ltd
၀.၀၀၀၁၀ US$
၀.၀၀%
(၀.၀၀) 1D
စက် ၁၄, GMT-၄ ၀၉:၃၉:၄၆ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REPCF...
Mkt. cap
၇.၃၆ ထောင်
Avg. vol.
၁.၉၈ ထောင်
Volume
၀.၀၀
P/E ratio
၀.၀၀
52-wk high
၀.၀၀ US$
52-wk low
၀.၀၀ US$
EPS
၀.၀၉ US$
Shares outstanding
၇.၃၆ ကုဋေ
No. of employees
၁
Mkt. cap
၇.၃၆ ထောင်
Avg. vol.
၁.၉၈ ထောင်
Volume
၀.၀၀
P/E ratio
၀.၀၀
52-wk high
၀.၀၀ US$
52-wk low
၀.၀၀ US$
EPS
၀.၀၉ US$
Shares outstanding
၇.၃၆ ကုဋေ
No. of employees
၁
News stories
From web sources and news partners
The Dark Side Of The Boom
·
ပြီးခဲ့သည့် ၂၈ မိနစ်
BTIG’s Krinsky Says the Million-Dollar Question Is Turning Into a Major Frustration
WSYR
·
ပြီးခဲ့သည့် ၅၅ မိနစ်
Asian shares mostly rise amid market optimism about AI, despite Iran worries
Barchart.com
·
ပြီးခဲ့သည့် ၂ နာရီ
What You Need To Know Ahead of Nasdaq's Earnings Release
WSJ
·
ပြီးခဲ့သည့် ၆ နာရီ
A Tech-Fueled Stock Market Powers Through, but Limps Into the Fourth Quarter
Profile
RepliCel Life Sciences is a Canadian regenerative medicine company based in Vancouver, British Columbia. The company focuses on development of cell therapies using a patient's own cells. The company has treatment development activities targeting chronic tendon injuries which have failed to heal properly, and hair restoration. The company's expertise lies in isolation and exploitation of different cell populations found in the human hair follicle.
The company's business model is focused on establishing proof-of-concept for treatments leading to acquisition by a larger company. An alternative business model has been reported which does not involve acquisition but rather partnership where technologies and methods are licensed to a partner which will commercialize them. Wikipedia
About 0913693 BC Ltd
CEO-
Employees၁
Founded၁၉၆၇
Headquartersဗန်ကူးဗားမြို့, ဗြိတိသျှ ကိုလံဘီယာ ပြည်နယ်, ကနေဒါ
Sector-
Websitereplicel.com